Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Perfuze

Perfuze Presents Preliminary Results from MARRS Pivotal Trial at SNIS, Highlighting Millipede88 Performance in Acute Ischemic Stroke
From Perfuze
Via Business Wire
Perfuze Announces Completion of Enrollment in Pivotal US Clinical Study and Appointment of Joe Rotger as Executive Vice President of Sales
From Perfuze
Via Business Wire
Perfuze Receives FDA 510(k) Clearance for Zipline™ Access Catheters and Secures €22M in Additional Funding
From Perfuze
Via Business Wire
Perfuze® Announces FDA Clearances for Novel Neurovascular Aspiration and Access Catheters for Stroke Treatment
From Perfuze
Via Business Wire
Perfuze® Announces First Stroke Patient Enrolled in the MARRS Pivotal Clinical Trial for the Millipede System
From Perfuze
Via Business Wire
Perfuze Announces Appointment of New Chair of the Board
From Perfuze
Via Business Wire
Perfuze Announces FDA Clearance and First U.S. Clinical Use of Millipede 088 Access Catheter
From Perfuze
Via Business Wire
Neurovascular Company Perfuze Raises €22.5m ($25m) Series A for New Stroke Treatment
From Perfuze
Via Business Wire
Perfuze Announces CE Mark and First Patients Treated with the Millipede 088
From Perfuze
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.